Theravance Biopharma Ownership 2024 | Who Owns Theravance Biopharma Now?
Institutional Ownership
97.57%
Insider Ownership
5.96%
Retail Ownership
-3.54%
Institutional Holders
132.00
Theravance Biopharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MADISON AVENUE PARTNERS, LP | 17.63% | 9.12% | 8,511,350 | 1,499,124 | 21.38% | 72,176,248 | Jun 30, 2024 |
| WEISS ASSET MANAGEMENT LP | 15.44% | 2.39% | 7,457,060 | - | - | 63,235,869 | Jun 30, 2024 |
| BAUPOST GROUP LLC/MA | 8.70% | 0.98% | 4,200,021 | -2,394,105 | -36.31% | 35,616,000 | Jun 30, 2024 |
| BLACKROCK INC. | 7.83% | 0.00% | 3,780,160 | -428,177 | -10.17% | 32,055,756 | Jun 30, 2024 |
| IRENIC CAPITAL MANAGEMENT LP | 5.72% | 2.86% | 2,760,948 | - | - | 23,412,839 | Jun 30, 2024 |
| NEWTYN MANAGEMENT, LLC | 4.40% | 3.38% | 2,124,703 | 480,773 | 29.25% | 18,017,481 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.15% | 0.00% | 2,002,179 | -683,674 | -25.45% | 16,978,478 | Jun 30, 2024 |
| PARK WEST ASSET MANAGEMENT LLC | 3.52% | 1.06% | 1,700,000 | 542,837 | 46.91% | 14,416,000 | Jun 30, 2024 |
| STATE STREET CORP | 2.62% | 0.00% | 1,267,375 | -101,406 | -7.41% | 10,747,340,000 | Jun 30, 2024 |
| OASIS MANAGEMENT CO LTD. | 2.40% | 2.21% | 1,157,965 | - | - | 9,819,543 | Jun 30, 2024 |
| CAMBER CAPITAL MANAGEMENT LP | 2.07% | 0.23% | 1,000,000 | - | - | 8,480,000 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.82% | 0.01% | 878,655 | -1,164,956 | -57.00% | 7,450,994 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.78% | 0.00% | 857,386 | -110,066 | -11.38% | 7,271,466 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.57% | 0.01% | 758,080 | -23,505 | -3.01% | 6,428,518 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.21% | 0.02% | 586,614 | 28,643 | 5.13% | 4,974,487 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.99% | 0.00% | 476,169 | -44,327 | -8.52% | 4,037,912 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.96% | 0.00% | 464,967 | -23,785 | -4.87% | 3,942,920,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.95% | 0.00% | 458,923 | 39,810 | 9.50% | 3,891,667 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.73% | 0.00% | 350,587 | 19,625 | 5.93% | 2,972,978 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.71% | 0.00% | 342,715 | 182,897 | 114.44% | 2,906,223 | Jun 30, 2024 |
Theravance Biopharma's largest institutional shareholder is MADISON AVENUE PARTNERS, LP, holding 17.63% of the company's total share outstanding, currently valued at $72.18M. The top 10 institutional shareholders own together 72.41% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MADISON AVENUE PARTNERS, LP | 17.63% | 9.12% | 8,511,350 | 1,499,124 | 21.38% | 72,176,248 | Jun 30, 2024 |
| NEWTYN MANAGEMENT, LLC | 4.40% | 3.38% | 2,124,703 | 480,773 | 29.25% | 18,017,481 | Jun 30, 2024 |
| IRENIC CAPITAL MANAGEMENT LP | 5.72% | 2.86% | 2,760,948 | - | - | 23,412,839 | Jun 30, 2024 |
| WEISS ASSET MANAGEMENT LP | 15.44% | 2.39% | 7,457,060 | - | - | 63,235,869 | Jun 30, 2024 |
| OASIS MANAGEMENT CO LTD. | 2.40% | 2.21% | 1,157,965 | - | - | 9,819,543 | Jun 30, 2024 |
| PARK WEST ASSET MANAGEMENT LLC | 3.52% | 1.06% | 1,700,000 | 542,837 | 46.91% | 14,416,000 | Jun 30, 2024 |
| BAUPOST GROUP LLC/MA | 8.70% | 0.98% | 4,200,021 | -2,394,105 | -36.31% | 35,616,000 | Jun 30, 2024 |
| CAMBER CAPITAL MANAGEMENT LP | 2.07% | 0.23% | 1,000,000 | - | - | 8,480,000 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.08% | 0.16% | 38,386 | 3,779 | 10.92% | 325,513 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.42% | 0.12% | 204,089 | 204,089 | 100.00% | 1,731,000 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.11% | 0.08% | 52,518 | 52,518 | 100.00% | 445,353 | Jun 30, 2024 |
| GERBER, LLC | 0.02% | 0.07% | 10,000 | - | - | 84,800 | Jun 30, 2024 |
| CHESCAPMANAGER LLC | 0.20% | 0.07% | 96,197 | -105,168 | -52.23% | 815,751 | Jun 30, 2024 |
| PETRUS TRUST COMPANY, LTA | 0.17% | 0.06% | 81,449 | 19,421 | 31.31% | 690,688 | Jun 30, 2024 |
| NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN | 0.12% | 0.06% | 58,142 | - | - | 493,044 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.14% | 0.05% | 66,439 | - | - | 563,403 | Jun 30, 2024 |
| YAKIRA CAPITAL MANAGEMENT, INC. | 0.03% | 0.05% | 15,122 | - | - | 128,234 | Jun 30, 2024 |
| INCEPTIONR LLC | 0.04% | 0.04% | 17,435 | 17,435 | 100.00% | 147,849 | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 0.09% | 0.03% | 44,180 | 28,678 | 185.00% | 374,646 | Jun 30, 2024 |
| CANTOR FITZGERALD, L. P. | 0.03% | 0.03% | 16,000 | -2,000 | -11.11% | 135,680 | Jun 30, 2024 |
The largest Theravance Biopharma shareholder by % of total assets is MADISON AVENUE PARTNERS, LP. The company owns 8.51M shares of Theravance Biopharma (TBPH), representing 9.12% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MADISON AVENUE PARTNERS, LP | 17.63% | 9.12% | 8,511,350 | 1,499,124 | 21.38% | 72,176,248 | Jun 30, 2024 |
| PARK WEST ASSET MANAGEMENT LLC | 3.52% | 1.06% | 1,700,000 | 542,837 | 46.91% | 14,416,000 | Jun 30, 2024 |
| NEWTYN MANAGEMENT, LLC | 4.40% | 3.38% | 2,124,703 | 480,773 | 29.25% | 18,017,481 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.54% | 0.00% | 259,259 | 228,396 | 740.03% | 2,198,517 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.42% | 0.12% | 204,089 | 204,089 | 100.00% | 1,731,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.71% | 0.00% | 342,715 | 182,897 | 114.44% | 2,906,223 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.62% | 0.00% | 297,499 | 135,426 | 83.56% | 2,522,792 | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.33% | 0.00% | 161,699 | 128,241 | 383.29% | 1,371,208 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.24% | 0.00% | 116,256 | 116,256 | 100.00% | 985,851 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.69% | 0.00% | 333,551 | 110,801 | 49.74% | 2,828,512 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.33% | 0.00% | 160,138 | 93,702 | 141.04% | 1,414,019 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.68% | 0.00% | 330,181 | 91,679 | 38.44% | 2,799,541 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.29% | 0.00% | 138,877 | 74,349 | 115.22% | 1,177,677 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.11% | 0.08% | 52,518 | 52,518 | 100.00% | 445,353 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.10% | 0.00% | 49,523 | 49,523 | 100.00% | 419,955 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.09% | 0.00% | 43,266 | 43,266 | 100.00% | 366,896 | Jun 30, 2024 |
| MORGAN STANLEY | 0.95% | 0.00% | 458,923 | 39,810 | 9.50% | 3,891,667 | Jun 30, 2024 |
| ALPS ADVISORS INC | 0.08% | 0.00% | 37,944 | 37,944 | 100.00% | 321,765 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.07% | 0.00% | 34,336 | 34,336 | 100.00% | 291,169 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.07% | 0.00% | 33,760 | 33,760 | 100.00% | 286,285 | Jun 30, 2024 |
As of Jun 30 2024, Theravance Biopharma's largest institutional buyer is MADISON AVENUE PARTNERS, LP. The company purchased 1.50M stocks of TBPH, valued at $72.18M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAUPOST GROUP LLC/MA | 8.70% | 0.98% | 4,200,021 | -2,394,105 | -36.31% | 35,616,000 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.82% | 0.01% | 878,655 | -1,164,956 | -57.00% | 7,450,994 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.15% | 0.00% | 2,002,179 | -683,674 | -25.45% | 16,978,478 | Jun 30, 2024 |
| BLACKROCK INC. | 7.83% | 0.00% | 3,780,160 | -428,177 | -10.17% | 32,055,756 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.78% | 0.00% | 857,386 | -110,066 | -11.38% | 7,271,466 | Jun 30, 2024 |
| CHESCAPMANAGER LLC | 0.20% | 0.07% | 96,197 | -105,168 | -52.23% | 815,751 | Jun 30, 2024 |
| STATE STREET CORP | 2.62% | 0.00% | 1,267,375 | -101,406 | -7.41% | 10,747,340,000 | Jun 30, 2024 |
| INVESCO LTD. | 0.09% | 0.00% | 44,123 | -81,778 | -64.95% | 374,163 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.00% | 0.00% | 1,452 | -51,424 | -97.25% | 12,095 | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.34% | 0.01% | 162,388 | -47,178 | -22.51% | 1,377,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.99% | 0.00% | 476,169 | -44,327 | -8.52% | 4,037,912 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | - | - | - | -43,447 | -100.00% | - | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | - | - | - | -40,166 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | 0.04% | - | 17,264 | -27,747 | -61.64% | 147,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.07% | 0.00% | 33,772 | -25,317 | -42.85% | 286,387 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -23,942 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.96% | 0.00% | 464,967 | -23,785 | -4.87% | 3,942,920,000 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 1.57% | 0.01% | 758,080 | -23,505 | -3.01% | 6,428,518 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.60% | 0.00% | 291,266 | -19,235 | -6.19% | 2,469,936 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.16% | 0.00% | 77,084 | -15,095 | -16.38% | 653,660 | Jun 30, 2024 |
As of Jun 30 2024, Theravance Biopharma's biggest institutional seller is BAUPOST GROUP LLC/MA. The company sold -2.39M shares of TBPH, valued at $35.62M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SHERBROOKE PARK ADVISERS LLC | 0.11% | 0.08% | 52,518 | 52,518 | 100.00% | 445,353 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.09% | 0.00% | 43,266 | 43,266 | 100.00% | 366,896 | Jun 30, 2024 |
| ALPS ADVISORS INC | 0.08% | 0.00% | 37,944 | 37,944 | 100.00% | 321,765 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.07% | 0.00% | 34,336 | 34,336 | 100.00% | 291,169 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.07% | 0.00% | 33,760 | 33,760 | 100.00% | 286,285 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.07% | 0.00% | 33,522 | 33,522 | 100.00% | 284,267 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 19,757 | 19,757 | 100.00% | 167,539 | Jun 30, 2024 |
| NEBULA RESEARCH & DEVELOPMENT LLC | 0.04% | 0.02% | 18,154 | 18,154 | 100.00% | 153,946 | Jun 30, 2024 |
| INCEPTIONR LLC | 0.04% | 0.04% | 17,435 | 17,435 | 100.00% | 147,849 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.03% | 0.00% | 16,023 | 16,023 | 100.00% | 135,875 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.03% | 0.01% | 15,196 | 15,196 | 100.00% | 128,862 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.03% | 0.00% | 12,829 | 12,829 | 100.00% | 107,764 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.03% | 0.00% | 12,139 | 12,139 | 100.00% | 102,939 | Jun 30, 2024 |
| STATE OF WYOMING | 0.01% | 0.01% | 4,951 | 4,951 | 100.00% | 41,984 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.00% | 0.00% | 1,824 | 1,824 | 100.00% | 15,464 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.00% | - | 334 | 334 | 100.00% | 2,000 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 237 | 237 | 100.00% | 1,974 | Jun 30, 2024 |
| COVESTOR LTD | 0.00% | 0.00% | 62 | 62 | 100.00% | 1,000 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | - | 57 | 57 | 100.00% | 484 | Jun 30, 2024 |
Theravance Biopharma's largest new institutional shareholder by number of shares is SHERBROOKE PARK ADVISERS LLC, purchased 52.52K shares, valued at $445.35K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JUMP FINANCIAL, LLC | - | - | - | -43,447 | -100.00% | - | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | - | - | - | -40,166 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -23,942 | -100.00% | - | Jun 30, 2024 |
| CORTON CAPITAL INC. | - | - | - | -14,888 | -100.00% | - | Jun 30, 2024 |
| PRINCIPAL FINANCIAL GROUP INC | - | - | - | -14,708 | -100.00% | - | Jun 30, 2024 |
| PROSHARE ADVISORS LLC | - | - | - | -12,219 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -11,576 | -100.00% | - | Jun 30, 2024 |
| MAN GROUP PLC | - | - | - | -10,101 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -5,834 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,773 | -100.00% | - | Jun 30, 2024 |
| DAIWA SECURITIES GROUP INC. | - | - | - | -215 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -13 | -100.00% | - | Jun 30, 2024 |
Theravance Biopharma's largest sold out institutional shareholder by shares sold is JUMP FINANCIAL, LLC, sold -43.45K shares, valued at -, as of undefined.
Theravance Biopharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BANCROFT FUND LTD | 1.08% | 1,500,000 | - | - | Dec 29, 2023 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 1.07% | 1,500,000 | - | - | Dec 29, 2023 |
| KKR Income Opportunities Fund | 0.62% | 3,900,000 | - | - | Jan 31, 2024 |
| WANGER ADVISORS TRUST | 0.42% | 229,782 | - | - | Mar 31, 2024 |
| Vanguard Montgomery Funds | 0.27% | 64,468 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.06% | 32,101 | - | - | Mar 31, 2024 |
| COLUMBIA ACORN TRUST | 0.03% | 105,821 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.03% | 317,371 | - | - | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.01% | 259,111 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.01% | 58,534 | - | - | Jan 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,625 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,231,525 | -1,268,080 | -36.23% | Mar 31, 2024 |
| MUTUAL OF AMERICA INSTITUTIONAL FUNDS INC | 0.00% | 2,290 | 2,290 | - | Sep 30, 2020 |
| VICTORY PORTFOLIOS | 0.00% | 104,880 | - | - | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 68,100 | - | - | Jan 31, 2024 |
| North Square Investments Trust | 0.00% | 24,670 | - | - | Jan 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 1,825 | - | - | Sep 30, 2023 |
| MML SERIES INVESTMENT FUND | 0.00% | 24,091 | - | - | Dec 31, 2023 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 77,465 | - | - | Mar 31, 2024 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.00% | 53,486 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 68,808 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 18,256 | - | - | Mar 31, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 394,000 | - | - | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 21,171 | -1,566 | -6.89% | Mar 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 58,051 | - | - | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 3,000 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 142,664 | -23,294 | -14.04% | Feb 29, 2024 |
| NEW COVENANT FUNDS | 0.00% | 2,200 | - | - | Dec 31, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 46,209 | 7,575 | 19.61% | Feb 29, 2024 |
| ProFunds | 0.00% | 4,604 | -305 | -6.21% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,031 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 159,971 | 82,999 | 107.83% | Jan 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 76,554 | 27,393 | 55.72% | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 45,795 | -5,227 | -10.24% | Mar 28, 2024 |
| Global X Funds | 0.00% | 14,047 | 46 | 0.33% | Feb 29, 2024 |
| Tidal ETF Trust | 0.00% | 3,263 | - | - | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 16,374 | -14,843 | -47.55% | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 10,929 | - | - | Feb 29, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 636 | - | - | Mar 28, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 3,981 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 613 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 225,962 | 4,304 | 1.94% | Feb 29, 2024 |
| RBB FUND, INC. | 0.00% | 6,387 | - | - | Feb 29, 2024 |
| Northern Lights Fund Trust IV | 0.00% | 18,425 | - | - | Jan 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,424 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 126,609 | -6,064 | -4.57% | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 85,000 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 172 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 4,451 | 546 | 13.98% | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 29,259 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 6,143 | 1,213 | 24.60% | Jan 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 2,770 | - | - | Mar 28, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 109,987 | 95,137 | 640.65% | Feb 29, 2024 |
| EMPOWER FUNDS, INC. | 0.00% | 25,204 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,181 | - | - | Feb 29, 2024 |
| VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00% | 42,227 | - | - | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 1,030 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 4,477 | 26 | 0.58% | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 264 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 30,242 | -220 | -0.72% | Dec 31, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 19,054 | -450 | -2.31% | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 2,954 | -12,696 | -81.12% | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 89,299 | -11,830 | -11.70% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 4,764 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 19,432 | -1,861 | -8.74% | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 114 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 17,375 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 7,036 | - | - | Feb 29, 2024 |
| Morningstar Funds Trust | 0.00% | 548,000 | - | - | Jan 31, 2024 |
Theravance Biopharma's largest mutual fund holder by % of total assets is "BANCROFT FUND LTD", owning 1.50M shares, compromising 1.08% of its total assets.
Theravance Biopharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 132 | 9.09% |
| 31 Mar, 24 | 121 | 1.68% |
| 31 Dec, 23 | 119 | 3.48% |
| 30 Sep, 23 | 115 | -5.74% |
| 30 Jun, 23 | 122 | 3.39% |
| 31 Mar, 23 | 118 | -7.81% |
| 31 Dec, 22 | 128 | -2.29% |
| 30 Sep, 22 | 131 | 16.96% |
| 30 Jun, 22 | 112 | -12.50% |
| 31 Mar, 22 | 128 | 10.34% |
| 31 Dec, 21 | 116 | -6.45% |
| 30 Sep, 21 | 124 | 13.76% |
| 30 Jun, 21 | 109 | -6.03% |
| 31 Mar, 21 | 116 | 11.54% |
| 31 Dec, 20 | 104 | -13.33% |
| 30 Sep, 20 | 120 | -4.76% |
| 30 Jun, 20 | 126 | 13.51% |
| 31 Mar, 20 | 111 | 1.83% |
| 31 Dec, 19 | 109 | 18.48% |
| 30 Sep, 19 | 92 | -11.54% |
| 30 Jun, 19 | 104 | -1.89% |
| 31 Mar, 19 | 106 | 10.42% |
| 31 Dec, 18 | 96 | 3.23% |
| 30 Sep, 18 | 93 | 3.33% |
| 30 Jun, 18 | 90 | -1.10% |
| 31 Mar, 18 | 91 | 8.33% |
| 31 Dec, 17 | 84 | -4.55% |
| 30 Sep, 17 | 88 | -8.33% |
| 30 Jun, 17 | 96 | - |
| 31 Mar, 17 | 96 | -4.00% |
| 31 Dec, 16 | 100 | - |
| 30 Sep, 16 | 100 | 2.04% |
| 30 Jun, 16 | 98 | 22.50% |
| 31 Mar, 16 | 80 | - |
| 31 Dec, 15 | 80 | 1.27% |
| 30 Sep, 15 | 79 | -9.20% |
| 30 Jun, 15 | 87 | 3.57% |
| 31 Mar, 15 | 84 | -7.69% |
| 31 Dec, 14 | 91 | - |
| 30 Sep, 14 | 91 | -2.15% |
| 30 Jun, 14 | 93 | 9200.00% |
| 31 Mar, 14 | 1 | - |
As of 30 Jun 24, 132 institutions are holding Theravance Biopharma's shares, representing an increase of 9.09% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 47,111,010 | -1.79% |
| 31 Mar, 24 | 47,969,701 | -1.71% |
| 31 Dec, 23 | 48,802,581 | -4.01% |
| 30 Sep, 23 | 50,842,548 | -3.68% |
| 30 Jun, 23 | 52,784,275 | -12.25% |
| 31 Mar, 23 | 60,151,138 | -3.09% |
| 31 Dec, 22 | 62,067,685 | -3.09% |
| 30 Sep, 22 | 64,049,961 | -0.25% |
| 30 Jun, 22 | 64,209,787 | 1.94% |
| 31 Mar, 22 | 62,987,379 | 6.15% |
| 31 Dec, 21 | 59,338,490 | -2.17% |
| 30 Sep, 21 | 60,655,344 | -0.17% |
| 30 Jun, 21 | 60,758,590 | 13.49% |
| 31 Mar, 21 | 53,537,682 | 0.56% |
| 31 Dec, 20 | 53,239,429 | 1.47% |
| 30 Sep, 20 | 52,465,742 | -0.94% |
| 30 Jun, 20 | 52,962,355 | -6.93% |
| 31 Mar, 20 | 56,904,445 | 26.96% |
| 31 Dec, 19 | 44,822,048 | -2.97% |
| 30 Sep, 19 | 46,191,833 | -5.00% |
| 30 Jun, 19 | 48,624,468 | 0.30% |
| 31 Mar, 19 | 48,479,616 | 1.65% |
| 31 Dec, 18 | 47,693,636 | 0.61% |
| 30 Sep, 18 | 47,402,490 | -0.96% |
| 30 Jun, 18 | 47,861,368 | 0.33% |
| 31 Mar, 18 | 47,702,773 | 1.65% |
| 31 Dec, 17 | 46,927,845 | -0.87% |
| 30 Sep, 17 | 47,337,550 | 2.23% |
| 30 Jun, 17 | 46,303,831 | 1.31% |
| 31 Mar, 17 | 45,704,317 | 4.31% |
| 31 Dec, 16 | 43,817,605 | 24.13% |
| 30 Sep, 16 | 35,300,065 | 4.08% |
| 30 Jun, 16 | 33,917,792 | 20.49% |
| 31 Mar, 16 | 28,150,873 | 8.35% |
| 31 Dec, 15 | 25,980,731 | 26.49% |
| 30 Sep, 15 | 20,539,617 | -8.42% |
| 30 Jun, 15 | 22,429,094 | 7.37% |
| 31 Mar, 15 | 20,888,707 | 1.85% |
| 31 Dec, 14 | 20,508,379 | -3.59% |
| 30 Sep, 14 | 21,271,607 | 4.78% |
| 30 Jun, 14 | 20,300,921 | 2410935.75% |
| 31 Mar, 14 | 842 | - |
Theravance Biopharma (TBPH) has 47.11M shares outstanding as of 30 Jun 24, down -1.79% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 97.57% | 0.99% |
| 31 Mar, 24 | 99.35% | 1.02% |
| 31 Dec, 23 | 98.76% | 1.05% |
| 30 Sep, 23 | 97.10% | 1.12% |
| 30 Jun, 23 | 93.12% | 1.02% |
| 31 Mar, 23 | 95.58% | 1.34% |
| 31 Dec, 22 | 84.34% | 1.17% |
| 30 Sep, 22 | 84.82% | 1.20% |
| 30 Jun, 22 | 84.19% | 1.20% |
| 31 Mar, 22 | 83.71% | 1.29% |
| 31 Dec, 21 | 80.61% | 1.19% |
| 30 Sep, 21 | 82.44% | 0.96% |
| 30 Jun, 21 | 92.52% | 1.34% |
| 31 Mar, 21 | 83.01% | 1.19% |
| 31 Dec, 20 | 83.55% | 1.22% |
| 30 Sep, 20 | 82.88% | 1.17% |
| 30 Jun, 20 | 84.25% | 0.92% |
| 31 Mar, 20 | 95.70% | 1.50% |
| 31 Dec, 19 | 79.89% | 1.17% |
| 30 Sep, 19 | 82.70% | 1.08% |
| 30 Jun, 19 | 87.57% | 1.12% |
| 31 Mar, 19 | 88.24% | 1.13% |
| 31 Dec, 18 | 88.37% | 1.16% |
| 30 Sep, 18 | 87.38% | 1.10% |
| 30 Jun, 18 | 88.96% | 1.11% |
| 31 Mar, 18 | 89.57% | 1.14% |
| 31 Dec, 17 | 88.70% | 1.10% |
| 30 Sep, 17 | 89.98% | 1.15% |
| 30 Jun, 17 | 88.61% | 1.13% |
| 31 Mar, 17 | 88.55% | 0.92% |
| 31 Dec, 16 | 98.00% | 1.70% |
| 30 Sep, 16 | 75.96% | 1.30% |
| 30 Jun, 16 | 76.38% | 1.42% |
| 31 Mar, 16 | 73.45% | 1.45% |
| 31 Dec, 15 | 71.10% | 1.91% |
| 30 Sep, 15 | 60.97% | 1.36% |
| 30 Jun, 15 | 66.89% | 1.65% |
| 31 Mar, 15 | 63.63% | 1.53% |
| 31 Dec, 14 | 64.58% | 1.44% |
| 30 Sep, 14 | 66.99% | 1.64% |
| 30 Jun, 14 | 63.90% | 892217562.96% |
| 31 Mar, 14 | 0.00% | - |
As of 30 Jun 24, Theravance Biopharma is held by 97.57% institutional shareholders, representing a 0.99% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 68 | 28.30% |
| 31 Mar, 24 | 53 | 15.22% |
| 31 Dec, 23 | 46 | 4.55% |
| 30 Sep, 23 | 44 | 4.76% |
| 30 Jun, 23 | 42 | -12.50% |
| 31 Mar, 23 | 48 | -15.79% |
| 31 Dec, 22 | 57 | -14.93% |
| 30 Sep, 22 | 67 | 48.89% |
| 30 Jun, 22 | 45 | -28.57% |
| 31 Mar, 22 | 63 | -4.55% |
| 31 Dec, 21 | 66 | -16.46% |
| 30 Sep, 21 | 79 | 29.51% |
| 30 Jun, 21 | 61 | 24.49% |
| 31 Mar, 21 | 49 | 6.52% |
| 31 Dec, 20 | 46 | -2.13% |
| 30 Sep, 20 | 47 | -36.49% |
| 30 Jun, 20 | 74 | - |
| 31 Mar, 20 | 74 | 19.35% |
| 31 Dec, 19 | 62 | 26.53% |
| 30 Sep, 19 | 49 | 2.08% |
| 30 Jun, 19 | 48 | -11.11% |
| 31 Mar, 19 | 54 | -1.82% |
| 31 Dec, 18 | 55 | 10.00% |
| 30 Sep, 18 | 50 | 31.58% |
| 30 Jun, 18 | 38 | -22.45% |
| 31 Mar, 18 | 49 | 16.67% |
| 31 Dec, 17 | 42 | 2.44% |
| 30 Sep, 17 | 41 | -14.58% |
| 30 Jun, 17 | 48 | 6.67% |
| 31 Mar, 17 | 45 | -30.77% |
| 31 Dec, 16 | 65 | 10.17% |
| 30 Sep, 16 | 59 | -14.49% |
| 30 Jun, 16 | 69 | 72.50% |
| 31 Mar, 16 | 40 | -4.76% |
| 31 Dec, 15 | 42 | 20.00% |
| 30 Sep, 15 | 35 | -31.37% |
| 30 Jun, 15 | 51 | 18.60% |
| 31 Mar, 15 | 43 | -14.00% |
| 31 Dec, 14 | 50 | 28.21% |
| 30 Sep, 14 | 39 | -56.67% |
| 30 Jun, 14 | 90 | 8900.00% |
| 31 Mar, 14 | 1 | - |
68 institutional shareholders have increased their position in TBPH stock as of 30 Jun 24 compared to 53 in the previous quarter (a 28.30% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 44 | -4.35% |
| 31 Mar, 24 | 46 | -4.17% |
| 31 Dec, 23 | 48 | 17.07% |
| 30 Sep, 23 | 41 | -18.00% |
| 30 Jun, 23 | 50 | 16.28% |
| 31 Mar, 23 | 43 | 2.38% |
| 31 Dec, 22 | 42 | 44.83% |
| 30 Sep, 22 | 29 | -30.95% |
| 30 Jun, 22 | 42 | 13.51% |
| 31 Mar, 22 | 37 | 19.35% |
| 31 Dec, 21 | 31 | 47.62% |
| 30 Sep, 21 | 21 | -22.22% |
| 30 Jun, 21 | 27 | -34.15% |
| 31 Mar, 21 | 41 | 28.13% |
| 31 Dec, 20 | 32 | -37.25% |
| 30 Sep, 20 | 51 | 70.00% |
| 30 Jun, 20 | 30 | 76.47% |
| 31 Mar, 20 | 17 | -39.29% |
| 31 Dec, 19 | 28 | 12.00% |
| 30 Sep, 19 | 25 | 19.05% |
| 30 Jun, 19 | 21 | 5.00% |
| 31 Mar, 19 | 20 | -13.04% |
| 31 Dec, 18 | 23 | 9.52% |
| 30 Sep, 18 | 21 | -22.22% |
| 30 Jun, 18 | 27 | 3.85% |
| 31 Mar, 18 | 26 | 4.00% |
| 31 Dec, 17 | 25 | 4.17% |
| 30 Sep, 17 | 24 | -7.69% |
| 30 Jun, 17 | 26 | -10.34% |
| 31 Mar, 17 | 29 | 81.25% |
| 31 Dec, 16 | 16 | -30.43% |
| 30 Sep, 16 | 23 | 27.78% |
| 30 Jun, 16 | 18 | -21.74% |
| 31 Mar, 16 | 23 | 9.52% |
| 31 Dec, 15 | 21 | -22.22% |
| 30 Sep, 15 | 27 | 50.00% |
| 30 Jun, 15 | 18 | -30.77% |
| 31 Mar, 15 | 26 | 8.33% |
| 31 Dec, 14 | 24 | -29.41% |
| 30 Sep, 14 | 34 | - |
| 30 Jun, 14 | - | - |
| 31 Mar, 14 | - | - |
44 institutional shareholders have reduced their position in TBPH stock as of 30 Jun 24 compared to 46 in the previous quarter (a -4.35% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 132 | 9.09% | 47,111,010 | -1.79% | 97.57% | 0.99% | 68 | 28.30% | 44 | -4.35% |
| 31 Mar, 24 | 121 | 1.68% | 47,969,701 | -1.71% | 99.35% | 1.02% | 53 | 15.22% | 46 | -4.17% |
| 31 Dec, 23 | 119 | 3.48% | 48,802,581 | -4.01% | 98.76% | 1.05% | 46 | 4.55% | 48 | 17.07% |
| 30 Sep, 23 | 115 | -5.74% | 50,842,548 | -3.68% | 97.10% | 1.12% | 44 | 4.76% | 41 | -18.00% |
| 30 Jun, 23 | 122 | 3.39% | 52,784,275 | -12.25% | 93.12% | 1.02% | 42 | -12.50% | 50 | 16.28% |
| 31 Mar, 23 | 118 | -7.81% | 60,151,138 | -3.09% | 95.58% | 1.34% | 48 | -15.79% | 43 | 2.38% |
| 31 Dec, 22 | 128 | -2.29% | 62,067,685 | -3.09% | 84.34% | 1.17% | 57 | -14.93% | 42 | 44.83% |
| 30 Sep, 22 | 131 | 16.96% | 64,049,961 | -0.25% | 84.82% | 1.20% | 67 | 48.89% | 29 | -30.95% |
| 30 Jun, 22 | 112 | -12.50% | 64,209,787 | 1.94% | 84.19% | 1.20% | 45 | -28.57% | 42 | 13.51% |
| 31 Mar, 22 | 128 | 10.34% | 62,987,379 | 6.15% | 83.71% | 1.29% | 63 | -4.55% | 37 | 19.35% |
| 31 Dec, 21 | 116 | -6.45% | 59,338,490 | -2.17% | 80.61% | 1.19% | 66 | -16.46% | 31 | 47.62% |
| 30 Sep, 21 | 124 | 13.76% | 60,655,344 | -0.17% | 82.44% | 0.96% | 79 | 29.51% | 21 | -22.22% |
| 30 Jun, 21 | 109 | -6.03% | 60,758,590 | 13.49% | 92.52% | 1.34% | 61 | 24.49% | 27 | -34.15% |
| 31 Mar, 21 | 116 | 11.54% | 53,537,682 | 0.56% | 83.01% | 1.19% | 49 | 6.52% | 41 | 28.13% |
| 31 Dec, 20 | 104 | -13.33% | 53,239,429 | 1.47% | 83.55% | 1.22% | 46 | -2.13% | 32 | -37.25% |
| 30 Sep, 20 | 120 | -4.76% | 52,465,742 | -0.94% | 82.88% | 1.17% | 47 | -36.49% | 51 | 70.00% |
| 30 Jun, 20 | 126 | 13.51% | 52,962,355 | -6.93% | 84.25% | 0.92% | 74 | - | 30 | 76.47% |
| 31 Mar, 20 | 111 | 1.83% | 56,904,445 | 26.96% | 95.70% | 1.50% | 74 | 19.35% | 17 | -39.29% |
| 31 Dec, 19 | 109 | 18.48% | 44,822,048 | -2.97% | 79.89% | 1.17% | 62 | 26.53% | 28 | 12.00% |
| 30 Sep, 19 | 92 | -11.54% | 46,191,833 | -5.00% | 82.70% | 1.08% | 49 | 2.08% | 25 | 19.05% |
| 30 Jun, 19 | 104 | -1.89% | 48,624,468 | 0.30% | 87.57% | 1.12% | 48 | -11.11% | 21 | 5.00% |
| 31 Mar, 19 | 106 | 10.42% | 48,479,616 | 1.65% | 88.24% | 1.13% | 54 | -1.82% | 20 | -13.04% |
| 31 Dec, 18 | 96 | 3.23% | 47,693,636 | 0.61% | 88.37% | 1.16% | 55 | 10.00% | 23 | 9.52% |
| 30 Sep, 18 | 93 | 3.33% | 47,402,490 | -0.96% | 87.38% | 1.10% | 50 | 31.58% | 21 | -22.22% |
| 30 Jun, 18 | 90 | -1.10% | 47,861,368 | 0.33% | 88.96% | 1.11% | 38 | -22.45% | 27 | 3.85% |
| 31 Mar, 18 | 91 | 8.33% | 47,702,773 | 1.65% | 89.57% | 1.14% | 49 | 16.67% | 26 | 4.00% |
| 31 Dec, 17 | 84 | -4.55% | 46,927,845 | -0.87% | 88.70% | 1.10% | 42 | 2.44% | 25 | 4.17% |
| 30 Sep, 17 | 88 | -8.33% | 47,337,550 | 2.23% | 89.98% | 1.15% | 41 | -14.58% | 24 | -7.69% |
| 30 Jun, 17 | 96 | - | 46,303,831 | 1.31% | 88.61% | 1.13% | 48 | 6.67% | 26 | -10.34% |
| 31 Mar, 17 | 96 | -4.00% | 45,704,317 | 4.31% | 88.55% | 0.92% | 45 | -30.77% | 29 | 81.25% |
| 31 Dec, 16 | 100 | - | 43,817,605 | 24.13% | 98.00% | 1.70% | 65 | 10.17% | 16 | -30.43% |
| 30 Sep, 16 | 100 | 2.04% | 35,300,065 | 4.08% | 75.96% | 1.30% | 59 | -14.49% | 23 | 27.78% |
| 30 Jun, 16 | 98 | 22.50% | 33,917,792 | 20.49% | 76.38% | 1.42% | 69 | 72.50% | 18 | -21.74% |
| 31 Mar, 16 | 80 | - | 28,150,873 | 8.35% | 73.45% | 1.45% | 40 | -4.76% | 23 | 9.52% |
| 31 Dec, 15 | 80 | 1.27% | 25,980,731 | 26.49% | 71.10% | 1.91% | 42 | 20.00% | 21 | -22.22% |
| 30 Sep, 15 | 79 | -9.20% | 20,539,617 | -8.42% | 60.97% | 1.36% | 35 | -31.37% | 27 | 50.00% |
| 30 Jun, 15 | 87 | 3.57% | 22,429,094 | 7.37% | 66.89% | 1.65% | 51 | 18.60% | 18 | -30.77% |
| 31 Mar, 15 | 84 | -7.69% | 20,888,707 | 1.85% | 63.63% | 1.53% | 43 | -14.00% | 26 | 8.33% |
| 31 Dec, 14 | 91 | - | 20,508,379 | -3.59% | 64.58% | 1.44% | 50 | 28.21% | 24 | -29.41% |
| 30 Sep, 14 | 91 | -2.15% | 21,271,607 | 4.78% | 66.99% | 1.64% | 39 | -56.67% | 34 | - |
| 30 Jun, 14 | 93 | 9200.00% | 20,300,921 | 2410935.75% | 63.90% | 892217562.96% | 90 | 8900.00% | - | - |
| 31 Mar, 14 | 1 | - | 842 | - | 0.00% | - | 1 | - | - | - |
Theravance Biopharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Theravance Biopharma's stock was made by Farnum Rhonda on Jul 12 2024, selling 4,000 shares at $9.00 per share (valued at $36.00K).
Theravance Biopharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | 1 | 100.00% |
| Q2 2024 | 22 | 5 | 440.00% |
| Q1 2024 | 2 | 11 | 18.18% |
| Q4 2023 | 5 | 8 | 62.50% |
| Q3 2023 | - | 9 | - |
| Q2 2023 | 14 | 9 | 155.56% |
| Q1 2023 | 9 | 10 | 90.00% |
| Q4 2022 | - | 8 | - |
| Q3 2022 | 1 | 6 | 16.67% |
| Q2 2022 | 12 | 5 | 240.00% |
| Q1 2022 | 3 | 7 | 42.86% |
| Q4 2021 | 3 | 10 | 30.00% |
| Q3 2021 | - | 9 | - |
| Q2 2021 | 20 | 9 | 222.22% |
| Q1 2021 | 9 | 11 | 81.82% |
| Q4 2020 | - | 11 | - |
| Q3 2020 | 5 | 13 | 38.46% |
| Q2 2020 | 18 | 9 | 200.00% |
| Q1 2020 | 16 | 9 | 177.78% |
| Q4 2019 | - | 9 | - |
1 total buy trades, and 1 total sell trades (buy/sell ratio of 1.00%) were made by Theravance Biopharma's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 1 | - |
| Q2 2024 | 2 | - | - |
| Q1 2024 | - | 1 | - |
| Q4 2023 | - | 3 | - |
| Q3 2023 | - | 4 | - |
| Q2 2023 | - | 4 | - |
| Q1 2023 | - | 3 | - |
| Q4 2022 | - | 2 | - |
| Q3 2022 | - | 2 | - |
| Q2 2022 | - | 1 | - |
| Q1 2022 | - | 1 | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 1 | - |
| Q4 2020 | - | 2 | - |
| Q3 2020 | - | 2 | - |
| Q2 2020 | - | 1 | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | 1 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Theravance Biopharma's stocks.
Theravance Biopharma Peer Ownership
| Ticker | Company |
|---|---|
| NUVB | Nuvation Bio Inc. |
| ACHL | Achilles Therapeutics plc |
| NXTC | NextCure, Inc. |
| SNSE | Sensei Biotherapeutics, Inc. |
| CTMX | CytomX Therapeutics, Inc. |
| GRPH | LENZ Therapeutics, Inc. |
| CNTB | Connect Biopharma Holdings Limited |
| ASMB | Assembly Biosciences, Inc. |
| OVID | Ovid Therapeutics Inc. |
| NLTX | Neurogene Inc. |
| MACK | Merrimack Pharmaceuticals, Inc. |
| TIL | Instil Bio, Inc. |
TBPH Ownership FAQ
Who Owns Theravance Biopharma?
Theravance Biopharma is owned by institutional shareholders (97.57%), insiders (5.96%), and public (-3.54%). The largest institutional shareholder of Theravance Biopharma is MADISON AVENUE PARTNERS, LP (17.63% of total shares) and the top mutual fund owner is BANCROFT FUND LTD (1.08% of total shares).
Who are the major institutional shareholders of Theravance Biopharma?
Theravance Biopharma's major institutional shareholders are MADISON AVENUE PARTNERS, LP, WEISS ASSET MANAGEMENT LP, BAUPOST GROUP LLC/MA, BLACKROCK INC., and IRENIC CAPITAL MANAGEMENT LP. The top five shareholders own together 55.32% of the company's share outstanding.
How many Theravance Biopharma shareholders are there?
As of Jun 2024, there are 132 institutional shareholders of Theravance Biopharma.
What percentage of Theravance Biopharma is owned by MADISON AVENUE PARTNERS, LP?
MADISON AVENUE PARTNERS, LP owns 8.51M shares of Theravance Biopharma, representing 17.63% of the company's total shares outstanding, valued at $72.18M (as of Jun 2024).
What percentage of Theravance Biopharma is owned by WEISS ASSET MANAGEMENT LP?
As of Jun 2024, WEISS ASSET MANAGEMENT LP holds 7.46M shares of Theravance Biopharma (TBPH), compromising 15.44% of the company, valued at $63.24M.
What percentage of Theravance Biopharma is owned by BAUPOST GROUP LLC/MA?
BAUPOST GROUP LLC/MA is the third largest holder of Theravance Biopharma. The company owns 4.2M of the company's shares outstanding (worth $35.62M).